Search company, investor...

Sontra Medical

Founded Year



Acquired | Acquired

Total Raised


About Sontra Medical

Developer of ultrasound technology for drug delivery, fluid withdrawal, and monitoring of glucose levels for diabetics. The company develops non-invasive diagnostic and transdermal drug delivery products which utilize low frequency ultrasound to increase skin permeability. The company is performing research and development on the SonoPrep Skin Permeation System. The system is being designed to provide a convenient and painless method of enhancing transport of molecules through human skin. After a brief application of ultrasound to skin, the skin would be permeable for an extended period of time (12 to 15 hours).

Headquarters Location

58 Charles Street

Cambridge, Massachusetts, 02141-2128,

United States


Missing: Sontra Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Sontra Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Sontra Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sontra Medical is included in 1 Expert Collection, including Diabetes.



1,895 items

Sontra Medical Frequently Asked Questions (FAQ)

  • When was Sontra Medical founded?

    Sontra Medical was founded in 1998.

  • Where is Sontra Medical's headquarters?

    Sontra Medical's headquarters is located at 58 Charles Street, Cambridge.

  • What is Sontra Medical's latest funding round?

    Sontra Medical's latest funding round is Acquired.

  • How much did Sontra Medical raise?

    Sontra Medical raised a total of $11M.

  • Who are the investors of Sontra Medical?

    Investors of Sontra Medical include Echo Therapeutics, H&Q Life Sciences Investors, Vanguard Ventures and Columbine Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.